October 14, 2026
Series Seed and NVCA documents are the two standard starting points for a startup’s priced equity round. Series Seed is the short form, three core documents for a first priced round led by angels or seed funds. The NVCA documents are the long form, a set of six that institutional investors expect at Series A and in larger seed rounds. The right choice usually depends on who is leading the round and what rights they want.
Key takeaways
The NVCA documents are model financing documents published by the National Venture Capital Association, the trade group for US venture investors. They were first released in the early 2000s, and NVCA updates them regularly. The core documents were most recently updated in 2025 and 2026. They are the default for Series A and later rounds, and most venture funds and their counsel know them line by line.
The Series Seed documents were released in 2010 as an open source, simplified alternative for seed-stage equity rounds. They keep the core economics of a preferred stock round but leave out much of the contractual machinery in the NVCA set.
| Series Seed | NVCA | |
|---|---|---|
| Core documents | Term sheet, stock investment agreement, amended and restated certificate of incorporation | Term sheet, stock purchase agreement, amended and restated certificate of incorporation, investors’ rights agreement, right of first refusal and co-sale agreement, voting agreement |
| Length | Roughly 50 pages | Well over 100 pages |
| Investor rights | Basic information rights, pro rata rights, protective provisions | Full information and registration rights, pro rata rights, ROFR and co-sale, drag-along, board voting arrangements, detailed protective provisions |
| Typical use | First priced round led by angels or seed funds | Series A and later, and seed rounds led by an institutional fund |
| Time and cost | Faster and less expensive | Slower and more expensive, because there is more to negotiate |
NVCA rounds often add ancillary documents such as a management rights letter and indemnification agreements for investor-appointed directors.
Let the lead investor’s needs drive the decision. The old rule of thumb that rounds under $2 million use Series Seed and larger rounds use NVCA no longer holds. Seed rounds of $2 million to $5 million are common, and many seed funds are happy with Series Seed at that size.
If your lead wants a board seat, registration rights, a voting agreement and the full set of NVCA protections, you’ll be on NVCA documents, and fighting it rarely saves money. If your round is led by angels or a seed fund that wants preferred stock without heavy governance, Series Seed gets you there faster and with lower legal fees on both sides. The real trade-off with Series Seed is fewer investor rights, which some leads won’t accept.
Most seed-stage companies raise on post-money SAFEs first, and the Series Seed or NVCA documents are used for the first priced round. You don’t need to do anything to convert SAFEs before that round. They convert automatically when the round closes, usually into a “shadow” series of the same preferred stock that carries the same rights but a different liquidation preference and conversion price, reflecting the SAFE’s lower effective price. Convertible notes convert under their own terms; well-drafted notes use the same shadow series approach.
Whether you call the round a “priced seed” or a “Series A” is mostly a label. The documents are the same kind either way. See SAFE and Startup Funding Stages.
The economics and control terms that attach to the preferred stock itself live in the amended and restated certificate of incorporation: the liquidation preference, anti-dilution protection, conversion rights, dividends, protective provisions, and the number of authorized shares. Contractual rights between the company and its stockholders live in the investor agreements: information rights, pro rata rights, the right of first refusal and co-sale, drag-along, and board voting arrangements.
On a Series Seed round, investors sign the stock investment agreement, and many of the contractual rights are folded into it. On an NVCA round, investors sign the stock purchase agreement plus the investors’ rights agreement, the ROFR and co-sale agreement and the voting agreement, and founders and other major stockholders sign the last two as well.
Neither set includes a separate subscription agreement. Investors make their representations, including accredited investor status, in the purchase agreement, and company counsel usually adds an accredited investor questionnaire. Depending on the type of fundraise, you may need to file a Form D and state blue sky filings.
Sometimes, though less often than they used to. A closing opinion is a formal letter from company counsel to the investors confirming a defined set of legal points, typically that the company is validly formed and in good standing, that it has authorized the financing, that the new shares are validly issued, and that the sale doesn’t need to be registered under securities laws. It isn’t a review of the whole business, and it doesn’t replace the investors’ own diligence.
The NVCA term sheet offers an opinion of company counsel as a closing condition, while Series Seed rounds rarely include one, and many seed and Series A leads now close without one. An opinion adds legal cost and time, because counsel has to check the company’s records before signing it. If a lead asks for one, it’s reasonable to ask them to drop it, especially in a smaller round.
Go deeper: For a full walkthrough, see our Founder Guide to Seed Funding and Founder Guide to Series A.
For more on the key terms, see Liquidation Preference, Protective Provisions, Pro Rata Rights and Multiple Closings. For help with your round, see our Series Seed and Series A services, or contact us.
